by Sue Robbins | Oct 4, 2019 | Migraine
The most important unmet need from my perspective is for a patient to get a diagnosis and [to determine] if their physician is capable of taking care of a patient with migraine. If a patient is having trouble getting good care from their physician, they need to find a...
by Sue Robbins | Sep 26, 2019 | Migraine
Despite an abundance of available options, patients with migraine are often dissatisfied with current abortive therapies. Studies indicate that up to a third of patients do not respond to triptans used as first-line therapies, and many more switch therapies regularly...
by Sue Robbins | Sep 23, 2019 | Migraine
Even mild long-term depressive symptoms among mothers are connected with emotional problems among small children such as hyperactivity, aggressiveness and anxiety. Read more here.
by Sue Robbins | Sep 19, 2019 | Migraine
Association between persistent back pain and persistent headaches identified by Warwick Medical School. A joined up approach to treatment is needed for those affected by both. Further research may uncover the links between the two and best treatment for those...
by Sue Robbins | Sep 18, 2019 | Migraine
A Glenbrook North High School senior who has suffered with migraine headaches for several years is using social media and other tools and partnerships to help raise aware for the condition that experts say can negatively impact young people’s quality of life. Read...
by Sue Robbins | Sep 17, 2019 | Migraine
Denmark’s Lundbeck has agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to reap profits from a potential blockbuster migraine drug. Read more here.
